Inari Medical Inc (NARI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,789 | 6,804 | 308 | 4,112 | -1,192 |
| Depreciation Amortization | 1,566 | 1,073 | 686 | 328 | 729 |
| Accounts receivable | -16,706 | -9,550 | -4,174 | -3,363 | N/A |
| Accounts payable and accrued liabilities | 498 | 984 | -255 | 315 | N/A |
| Other Working Capital | -21,169 | -10,280 | -7,200 | -6,046 | -6,321 |
| Other Operating Activity | 23,934 | 14,505 | 8,830 | 3,975 | 1,848 |
| Operating Cash Flow | $1,912 | $3,536 | $-1,805 | $-679 | $-4,936 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,460 | -3,076 | -1,418 | -609 | -3,144 |
| Purchase Of Investment | -49,977 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-55,437 | $-3,076 | $-1,418 | $-609 | $-3,144 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | 10,000 | N/A |
| Debt Repayment | -30,250 | -30,250 | N/A | N/A | N/A |
| Common Stock Issued | 164,832 | 164,592 | 164,432 | 22 | N/A |
| Other Financing Activity | -467 | -453 | -12 | 0 | 10,223 |
| Financing Cash Flow | $144,115 | $143,889 | $174,420 | $10,022 | $10,223 |
| Beginning Cash Position | 24,027 | 24,027 | 24,027 | 24,027 | 21,884 |
| End Cash Position | 114,617 | 168,376 | 195,224 | 32,761 | 24,027 |
| Net Cash Flow | $90,590 | $144,349 | $171,197 | $8,734 | $2,143 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,912 | 3,536 | -1,805 | -679 | -4,936 |
| Capital Expenditure | -5,460 | -3,076 | -1,418 | -609 | N/A |
| Free Cash Flow | -3,548 | 460 | -3,223 | -1,288 | -4,936 |